|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rb function in cell-cycle regulation and apoptosis 显示文摘 | HARBOUR J W DEAN D C | 2000 | Nat Cell Biol2000，2，4： | 1 |
| 2 | Weighted norm inequalities for commtators of strongly singular intergrals显示文摘 | Garcia-Cuerva J Harboure E Segovia C | 1991 | Indiana Univ Math1991，40，： | 1 |
| 3 | Weighted norm inequalities for commutators of strongly singular integrals显示文摘 | GARCIA-CUERVA J HARBOUR E SEGOVIA C | 1991 | Indiana Univ Math J1991，40，： | 1 |
| 4 | Weighted norm inequalities for commutators of strongly singular integrals显示文摘 | Garcia - Cuerva J Harboure E Segovia C Torrea J | 1991 | Indiana Univ Math J1991，40，： | 1 |
| 5 | The Rh-F2F pathway:expanding roles and emerging paradignts显示文摘 | Harbour J W Dean D C | 2000 | Cenes Dev2000，14，19： | 1 |
| 6 | Eudis- tomins C, E, K and L, potent antiviral compounds contai- ning a novel oxathiazepine ring from Caribbean tunicate Eu- distomaolivaceum显示文摘 | Rinehart K L Kobayashi J Harbour O C | 1984 | J Am Chem Soc1984，106，15： | 1 |
| 7 | Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth 显示文摘 | Manos J Arthur J Rose B Bell S Tingpej P Hu H Webb J Kjelleberg S Gorrell MD Bye P Harbour C | 2009 | FEMS Microbiol Lett2009，292，1： | 1 |
| 8 | Rb function in cell-cycle regulation and apoptosis显示文摘 | Harbour J W Dean D C | 2000 | Nat Cell Biol2000，2，： | 1 |
| 9 | The Rb E2F pathway:expanding roles and emerging paradigms显示文摘 | Harbour J W Dean D C | 2000 | Genes Dev2000，14，19： | 1 |
| 10 | Natural and experimental astrovirus infection of cats显示文摘 | HARBOUR D A ASHLEY C R WILLIAMS P D | 1987 | Vet Rec1987，120，23： | 1 |
| 11 | Chromatin remodeling and Rb activity显示文摘 | J William Harbour Douglas C Dean | 2000 | Current Opinion in Cell Biology2000，，6： | 1 |
| 12 | The Rb/E2F pathway: expanding roles and emerging paradigms显示文摘 | Harbour J W Dean D C | 2000 | Genes Dev2000，14，19： | 1 |
| 13 | Descriptive norms and male youth smoking in rural Minya,Egypt:a multilevel analysis of household and neighborhood normative influences显示文摘 | Harbour C | 2012 | Nicotine Tob Res2012，14，7： | 1 |
| 14 | The Rb/E2F pathway: Expand- ing roles and emerging paradigms显示文摘 | Harbour J W Dean D C | 2000 | Genes & Devel- opment2000，14，19： | 1 |
| 15 | Weighted norm inequalities for commutators of strongly singular integrals显示文摘 | Gareia-Cuerva J Harboure E Segovia C | 1991 | In diana Univ Math J1991，40，： | 1 |
| 16 | Weighted norm inequalities for commotators of strongly singular integrals 显示文摘 | Garcia-Cuerva J Harboure E Segovia C | 1991 | Indiana Univ Math J1991，41，： | 1 |
| 17 | Holistic Schedulability Analysis for Multipacket Messages in AFDX Networks显示文摘 | Gutiarrez J J Palencia J C Harbour M G | 2014 | Real-time Systems2014，50，2： | 1 |
| 18 | RB function in cell-cycle regulation and apoptosis显示文摘 | DEAN D C | 2000 | Nature Cell Biology2000，2，4： | 1 |
| 19 | An international survey of classification and treatment choices for group D retinoblastoma显示文摘AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.METHODS: An anonymized electronic survey was offered to 115 physicians at 39 retinoblastoma centers worldwide asking about IIRC classification schemes and treatment patterns used between 2008 and 2012. Participants were asked to record which version of the IIRC was used for classification, how many group D eyes were diagnosed, and how many eyes were treated with enucleation versus globe salvaging therapies. Averages of eyes per treatment modality were calculated and stratified by both IIRC version and geographic region. Statistical significance was determined by Chi-square, ANOVA and Kruskal-Wallis tests using Prism.RESULTS: The survey was completed by 29% of physicians invited to participate. Totally 1807 D eyes were diagnosed. Regarding IIRC system, 27% of centers used the Children's Hospital of Los Angeles(CHLA) version, 33% used the Children's Oncology Group(COG) version, 23% used the Philadelphia version, and 17% were unsure. The rate for primary enucleation varied between 0 and 100% and the mean was 29%. By IIRC version, primary enucleation rates were: Philadelphia, 8%; COG, 34%; and CHLA, 37%. By geographic region, primary enucleation rates were: Latin America, 57%; Asia, 40%; Europe, 36%; Africa, 10%, US, 8%; and Middle East, 8%. However, systemic chemoreduction was used more often than enucleation in all regions except Latin America with a mean of 57% per center(P<0.0001). CONCLUSION: Worldwide there is no consensus on which IIRC version is used, systemic chemoreduction was the most frequently used initial treatment during the study period followed by enucleation and primary treatment modality, especially enucleation, varied greatly with regards to IIRC version used and geographic region. | Christina Scelfo Jasmine H Francis Vikas Khetan Thomas Jenkins Brian Marr David H Abramson Carol L Shields Jacob Pe’er Francis Munier Jesse Berry J.William Harbour Andrey Yarovoy Evandro Lucena Timothy G Murray Pooja Bhagia Evelyn Paysse Samuray Tuncer Guillermo L Chantada Annette C Moll Tatiana Ushakova David A Plager Islamov Ziyovuddin Carlos A Leal Miguel A Materin Xun-Da Ji Jose W Cursino Rodrigo Polania Hayyam Kiratli Charlotta All-Ericsson Rejin Kebudi Santosh G Honavar Vicktoria Vishnevskia-Dai Sidnel Epelman Anthony B Daniels Jeanie D Ling Fousseyni Traore Marco A Ramirez-Ortiz | 2017 | International Journal of Ophthalmology(English edition)2017，10，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员